<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9126">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988128</url>
  </required_header>
  <id_info>
    <org_study_id>MDT16056</org_study_id>
    <nct_id>NCT02988128</nct_id>
  </id_info>
  <brief_title>Neurovascular Product Surveillance Registry</brief_title>
  <acronym>INSPIRE</acronym>
  <official_title>NeuroVascular Product Surveillance Registry (PSR) Platform</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Neurovascular Clinical Affairs</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic Neurovascular Clinical Affairs</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post market surveillance registry
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An observational, prospective, multi-center, single-arm registry to provide continuing
      evaluation and periodic reporting of safety and effectiveness of Medtronic Neurovascular
      market-released products used in the treatment of Intracranial aneurysms.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>The clinical success rate defined as complete occlusion of target aneurysm without retreatment or significant artery stenosis (≤ 50%).</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment for intracranial aneurysms</intervention_name>
    <description>Embolization of aneurysms</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring treatment for intracranial aneurysms with market approved flow
        diverters,intrasaccular devices or vascular reconstruction devices are eligible for the
        registry.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient or legally authorized representative provides written authorization and/or
             consent per institution and geographical requirements

          -  Patient is intended to receive treatment with an eligible product

          -  Patient within enrollment window of treatment/therapy received at the time of their
             initial enrollment.

        Exclusion Criteria:

          -  Patient who is, or is expected to be inaccessible for follow-up

          -  Patient with exclusion criteria required by local law

          -  Patient is currently enrolled in or plans to enroll in any concurrent drug and/or
             device study that may confound results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Holtmannspotter, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, University of Copenhagen, Department of Neuroradiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurent Spelle, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Bicêtre, Service de Neuroradiologie Interventionnelle Adulte et Pédiatrique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Fiehler, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_official>
    <last_name>István Szikora, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Institute of Clinical Neurosciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario Galdamez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fundación Jiménez Díaz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Saleh Lamin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Queen Elisabeth Hospital, Neuroradiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine Cuijpers</last_name>
    <phone>+31433566831</phone>
    <email>antoine.cuijpers@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inge Kuijpers</last_name>
    <phone>+31433566846</phone>
    <email>inge.kuijpers@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Foundation Ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Piotin, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 17, 2016</lastchanged_date>
  <firstreceived_date>December 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Embolization Device</keyword>
  <keyword>Flow Diverter</keyword>
  <keyword>Intra saccular device</keyword>
  <keyword>Vascular Reconstruction Device</keyword>
  <keyword>Ruptured Intracranial Aneurysm</keyword>
  <keyword>Unruptured Intracranial Aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
